Detalles de la búsqueda
1.
Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study).
Oncologist
; 27(4): 328-333, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380718
2.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318983
3.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676789
4.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30299429
5.
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Lancet Oncol
; 16(7): 787-94, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26028518
6.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC Cancer
; 15: 222, 2015 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884302
7.
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
BJU Int
; 115(1): 65-73, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24180479
8.
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Lancet Oncol
; 15(13): 1442-1450, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25456363
9.
Nivolumab-induced bullous pemphigoid after radiotherapy and abscopal effect.
Australas J Dermatol
; 60(3): e235-e236, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592031
10.
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 14(2): 149-58, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23306100
11.
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
Support Care Cancer
; 21(7): 1947-54, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23420555
12.
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Clin Genitourin Cancer
; 21(5): 615.e1-615.e8, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263910
13.
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial.
Lancet Oncol
; 12(7): 673-80, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21664867
14.
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial.
Eur Urol
; 81(3): 234-240, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789394
15.
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Cancer Med
; 10(7): 2250-2258, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675184
16.
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Eur J Cancer
; 158: 1-11, 2021 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619467
17.
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer.
Clin Cancer Res
; 14(18): 5907-12, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794104
18.
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
JAMA Oncol
; 5(5): 623-632, 2019 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703190
19.
Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
Eur Urol
; 73(5): 696-703, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074061
20.
Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study.
Clin Cancer Res
; 23(23): 7171-7179, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28928162